By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Minerva Surgical, Inc.

Minerva Surgical, Inc. (UTRS)

OTC Currency in USD
$0.00
$0.00
+900.00%
Last Update: 29 Aug 2025, 00:00
$888.00
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.01
52 Week Range

UTRS Stock Price Chart

Explore Minerva Surgical, Inc. interactive price chart. Choose custom timeframes to analyze UTRS price movements and trends.

UTRS Company Profile

Discover essential business fundamentals and corporate details for Minerva Surgical, Inc. (UTRS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

IPO Date

22 Oct 2021

Employees

174.00

CEO

Darin Hammers

Description

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

UTRS Financial Timeline

Browse a chronological timeline of Minerva Surgical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 13 Feb 2025

Earnings released on 27 Dec 2024

Earnings released on 9 Aug 2024

Earnings released on 14 Jun 2024

Earnings released on 19 Mar 2024

Earnings released on 13 Nov 2023

EPS came in at -$0.81 surpassing the estimated -$1.00 by +19.00%, while revenue for the quarter reached $11.97M , missing expectations by -13.92%.

Stock split effective on 2 Oct 2023

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 2 Aug 2023

EPS came in at -$1.00 surpassing the estimated -$1.80 by +44.44%, while revenue for the quarter reached $13.39M , beating expectations by +1.37%.

Earnings released on 2 May 2023

EPS came in at -$2.40 falling short of the estimated -$2.20 by -9.09%, while revenue for the quarter reached $12.53M , meeting expectations.

Earnings released on 21 Mar 2023

EPS came in at -$4.00 falling short of the estimated $0.21 by -2.00K%, while revenue for the quarter reached $13.80M , missing expectations by -7.97%.

Earnings released on 14 Nov 2022

EPS came in at -$8.00 falling short of the estimated -$5.60 by -42.86%, while revenue for the quarter reached $12.59M , missing expectations by -16.08%.

Earnings released on 9 Aug 2022

EPS came in at -$4.00 surpassing the estimated -$6.80 by +41.18%, while revenue for the quarter reached $12.97M .

Earnings released on 11 May 2022

EPS came in at -$7.60 falling short of the estimated -$6.20 by -22.58%, while revenue for the quarter reached $10.94M , beating expectations by +1.53%.

Earnings released on 8 Mar 2022

EPS came in at -$0.26 surpassing the estimated -$0.29 by +10.34%, while revenue for the quarter reached $13.65M , beating expectations by +25.76%.

Earnings released on 2 Dec 2021

EPS came in at $4.87 surpassing the estimated -$0.44 by +1.21K%, while revenue for the quarter reached $12.51M .

Earnings released on 25 Oct 2021

EPS came in at -$13.82 , while revenue for the quarter reached $14.11M .

Earnings released on 31 Mar 2021

EPS came in at -$14.66 , while revenue for the quarter reached $11.84M .

Earnings released on 31 Dec 2020

EPS came in at -$0.31 , while revenue for the quarter reached $13.55M .

Earnings released on 30 Sept 2020

EPS came in at -$7.18 , while revenue for the quarter reached $12.28M .

UTRS Stock Performance

Access detailed UTRS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run